Drawing for GUIDENT

USPTO serial 97187262

GUIDENT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RUTLAND, BARBARA A
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GUIDENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Megan C. Hymore

Megan C. Hymore Dinsmore & Shohl, LLP255 E. Fifth streetSuite 1900Cincinnati, OH 45202

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for use in medical decision support systems; Downloadable computer software for employing computer algorithms for medical data analysis in the medical field; Downloadable computer software for controlling medical apparatus comprising of medical algorithms; Downloadable computer software for medical diagnosis comprising of medical algorithms; Downloadable medical software for capturing, recording, storing, monitoring, analyzing and managing medical imaging data using artificial intelligence; Downloadable computer software using artificial intelligence for assisting decision-making in the medical field; Recorded computer software and hardware for assisting decision-making in the medical field using artificial intelligence sold as a unit; Recorded computer software and hardware for employing computer algorithms for medical data analysis in the medical field sold as a unit; Recorded computer software and hardware for comprising medical algorithms for medical diagnosis and controlling medical apparatus sold as a unit; Recorded computer software and hardware for use in capturing, recording, storing, monitoring, analyzing and managing medical imaging data using artificial intelligence sold as a unitACTIVE—
042Platform as a service (PAAS) featuring computer software platforms for medical diagnosis assistance in the medical field; Providing a website featuring non-downloadable software using artificial intelligence for in medical imaging in the medical field; Providing a website featuring non-downloadable software using artificial intelligence for medical diagnosis assistance in the medical field; Providing a website featuring non-downloadable software using artificial intelligence for the collection and processing of resting phase biological signals through algorithms, machine-learning technology, and modeling techniques for diagnostic and predictive medical applications; Providing a website featuring non-downloadable software using artificial intelligence for use in capturing, recording, storing, monitoring, analyzing and managing medical imaging data; Software as a service (SAAS) services featuring software for the collection and processing of resting phase biological signals through algorithms, machine-learning technology, and modeling techniques for diagnostic and predictive medical applications; Software as a service (SAAS) services featuring software for in medical imaging in the medical fieldACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 26, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 26, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 22, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 21, 2025EX5GSOU EXTENSION 5 GRANTED—
Oct 21, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 29, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 28, 2025EXT5SOU EXTENSION 5 FILED—
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 17, 2024EX4GSOU EXTENSION 4 GRANTED—
Dec 16, 2024EXT4SOU EXTENSION 4 FILED—
Dec 16, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 6, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 5, 2024EX3GSOU EXTENSION 3 GRANTED—
Apr 5, 2024EXT3SOU EXTENSION 3 FILED—
Apr 5, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 28, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 26, 2023EX2GSOU EXTENSION 2 GRANTED—
Dec 26, 2023EXT2SOU EXTENSION 2 FILED—
Dec 26, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 29, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 27, 2023EX1GSOU EXTENSION 1 GRANTED—
Jun 27, 2023EXT1SOU EXTENSION 1 FILED—
Jun 27, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 26, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 26, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 26, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 26, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 26, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 27, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 1, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 1, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 12, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 29, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 27, 2022DOCKASSIGNED TO EXAMINER—
Dec 30, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 27, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance